शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
INDORAMANSEINDO RAMA SYNTHETICS LTD· Textiles & ApparelsHighNeutral
Announced Fri, 16 Oct, 2026 · 14:55 IST

Q2 FY27 results: PAT surges but H1 revenue dips YoY

Revenue declinedProfit growth above 25%EBITDA margin expansionResults View source PDFExplain this filing

INDORAMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.6%Reaction day
₹93.60
prior close
₹95.57
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+2.9% vs market
Other Textile Products peers, median of 187sector+0.0%+3.6% vs sector

On the reaction day the stock moved 2.9 pts more than Nifty Microcap 250 and 3.6 pts more than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.9
10m
+1.7
15m
+1.2
30m
+1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+3.6+0.7+2.9+0.0+3.6
Next day
-2.0-1.0-1.1-1.0-1.0
2d
-11.3-3.6-7.7-2.9-8.4
3d
-18.3-4.5-13.7-2.9-15.4
4d
-20.3-6.8-13.5-5.1-15.2
5d
-19.9-6.4-13.5-5.0-14.9
1w
-20.0-4.7-15.3-4.5-15.5
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 187Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indo Rama Synthetics reported Q2 FY27 results. Standalone Q2 revenue rose 7% YoY to Rs 1,248 cr but H1 revenue fell 12% to Rs 2,066 cr. Standalone Q2 PAT jumped 138% to Rs 55 cr; H1 PAT up 60% to Rs 89 cr. Consolidated Q2 PAT surged 201% to Rs 74 cr; H1 PAT up 78% to Rs 138 cr. Operating margins improved notably due to lower raw material costs. Auditor issued a clean limited review.

Likely market impact

Strong PAT growth and margin expansion despite topline weakness, suggesting better cost management.